- Report
- February 2024
- 259 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- August 2021
- 175 Pages
Global
From €2643EUR$2,750USD£2,267GBP
€5286EUR$5,500USD£4,533GBP
- Report
- May 2023
- 187 Pages
Global
From €5719EUR$5,950USD£4,904GBP
- Report
- March 2019
- 159 Pages
Global
From €3061EUR$3,185USD£2,625GBP
€4373EUR$4,550USD£3,750GBP
- Report
- January 2021
- 90 Pages
North America
From €4565EUR$4,750USD£3,915GBP
The Patent Cliff market is a term used to describe the pharmaceutical industry when a large number of drugs come off patent at the same time. This can lead to a decrease in revenue for the companies that manufacture the drugs, as generic versions of the drugs become available. The Patent Cliff market is a period of intense competition between pharmaceutical companies, as they attempt to maintain their market share and profits. Companies must focus on developing new drugs and expanding their product portfolios in order to remain competitive.
Companies in the Patent Cliff market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, and Johnson & Johnson. Show Less Read more